Scarica l'app Stockscreener
1.015
13.25%
-0.155
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1.17
Aprire:
$1.16
Volume 24 ore:
803.63K
Relative Volume:
0.29
Capitalizzazione di mercato:
$15.11M
Reddito:
$3,000
Utile/perdita netta:
$-7.78M
Rapporto P/E:
-0.9811
EPS:
-1.0346
Flusso di cassa netto:
$-7.49M
1 W Prestazione:
-18.15%
1M Prestazione:
-1.46%
6M Prestazione:
-22.52%
1 anno Prestazione:
-51.67%
Intervallo 1D:
$1.00
$1.16
Intervallo di 1 settimana:
$1.00
$1.255
Portata 52W:
$0.7765
$2.45
Biocardia Inc Stock (BCDA) Company Profile
Nome
Biocardia Inc
Settore
Industria
Telefono
650-226-0123
Indirizzo
320 SOQUEL WAY, SUNNYVALE, CA
Compare BCDA vs MOBBW, GOODO, PSNYW, SHMD, DWLD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
| 0.41 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
2.49 | 2.97B | 0 | 0 | 0 | 0.00 |
GOODO
Gladstone Commercial Corporation
|
20.01 | 372.90M | 0 | 0 | 0 | 0.00 |
PSNYW
Polestar Automotive Holding Uk
|
2.20 | 349.09M | 2.07B | -1.42B | -1.37B | -0.6765 |
SHMD
Schmid Group N V
|
4.72 | 358.07M | 52.15M | -21.46M | 0 | -0.4675 |
DWLD
Davis Select Worldwide ETF
|
47.37 | 0 | 0 | 0 | 0 | 0.00 |
Biocardia Inc Stock (BCDA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-04-16 | Downgrade | Dawson James | Buy → Neutral |
Biocardia Inc Borsa (BCDA) Ultime notizie
BCDABioCardia Inc Latest SEC Filings - Finviz
BioCardia (BCDA) CFO granted 60,483 RSUs as stock compensation - Stock Titan
Form 4 Biocardia Inc For: 1 July By Investing.com - Investing.com UK
BioCardia (BCDA) CEO Peter Altman granted 110,625 fully vested RSUs - Stock Titan
BioCardia (BCDA) SVP awarded 39,521 RSUs fully vesting on June 29, 2026 - Stock Titan
BCDA Q1 2026 Earnings: Wider-than-Expected Loss Amid No Revenue, Stock Jumps 10%Debt Analysis Report - dars.gov.et
Price to book forward of BioCardia, Inc. – NASDAQ:BCDA - TradingView
BioCardia, Inc. Actuals & Estimates (NASDAQ:BCDA) - TradingView
BCDA Forecast — Price Target — Prediction for 2027 - TradingView
Enterprise value to revenue forward of BioCardia, Inc. – NASDAQ:BCDA - TradingView
BioCardia Inc (BCDA) Valuation: PE, PB & Fair Value Analysis - TradingKey
Enterprise value to EBITDA forward of BioCardia, Inc. – NASDAQ:BCDA - TradingView
BioCardia director Simon Stertzer buys $103,584 in common stock - Investing.com UK
BioCardia director Simon Stertzer buys $103,584 in common stock By Investing.com - Investing.com South Africa
Form 4 Biocardia Inc For: 24 June By Investing.com - Investing.com Australia
Director Stertzer (BCDA) adds 109,200 BioCardia shares in open-market buys - Stock Titan
BioCardia Inc (BCDA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
BioCardia president & CEO Peter Altman buys $2,043 in stock - Investing.com UK
BioCardia president & CEO Peter Altman buys $2,043 in stock By Investing.com - Investing.com South Africa
Form 4 Biocardia Inc For: 22 June By Investing.com - Investing.com Nigeria
BioCardia (BCDA) CEO adds 2,300 shares in open-market buys - Stock Titan
BioCardia (BCDA) Moves Higher Near Resistance – Testing Key LevelsMomentum Stock Picks - dars.gov.et
BioCardia shares rally after FDA supports regulatory path for heart failure therapy (BCDA) - MSN
BioCardia (BCDA) Shares Strategic Business Update Following Capi - GuruFocus
BioCardia Outlines 2026 Strategic Priorities: Japan CardiAMP Submission, U.S. Expansion, and New Partnership Opportunities – Minichart - Minichart
BioCardia's High-Stakes Gambit: A Japan-First Strategy for Heart Therapy - BriefGlance
symbol__ Stock Quote Price and Forecast - CNN
BioCardia plans Japan regulatory submission for heart therapy By Investing.com - Investing.com South Africa
BioCardia plans Japan regulatory submission for heart therapy - Investing.com
BioCardia Inc (BCDA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
BioCardia Outlines 2026 CardiAMP Strategy and Milestones - TipRanks
BioCardia Letter to Stockholders on 2026 Priorities and Strategic Opportunities - The Manila Times
BioCardia targets Japan PMDA submission for CardiAMP, advances U.S. trial and partnership opportunities - TradingView
BioCardia (NASDAQ: BCDA) details Japan approval push and 2026 catalysts - Stock Titan
BioCardia Inc (BCDA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
BioCardia Inc (BCDA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
BioCardia Inc (BCDA) Institutional Confidence - TradingKey
BioCardia Inc (BCDA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
BioCardia Inc (BCDA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
BioCardia Inc (BCDA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Biocardia Inc Azioni (BCDA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Biocardia Inc Azioni (BCDA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| STERTZER SIMON H | Director |
Jun 23 '26 |
Buy |
1.00 |
39,000 |
39,000 |
166,338 |
| Altman Peter | President and CEO |
Jun 17 '26 |
Buy |
0.85 |
1,500 |
1,275 |
299,766 |
| Altman Peter | President and CEO |
Jun 18 '26 |
Buy |
0.96 |
800 |
768 |
300,566 |
| Altman Peter | President and CEO |
Jun 09 '26 |
Buy |
0.85 |
5,000 |
4,250 |
298,266 |
| Altman Peter | President and CEO |
May 20 '26 |
Buy |
0.92 |
1,500 |
1,380 |
293,266 |
| Altman Peter | President and CEO |
May 19 '26 |
Buy |
0.95 |
200 |
190 |
291,766 |
| Altman Peter | President and CEO |
May 18 '26 |
Buy |
0.92 |
5,700 |
5,244 |
291,566 |
| Altman Peter | President and CEO |
May 15 '26 |
Buy |
1.02 |
5,100 |
5,202 |
285,866 |
| Altman Peter | President and CEO |
Apr 29 '26 |
Buy |
1.11 |
5,000 |
5,550 |
280,766 |
| Altman Peter | President and CEO |
Apr 20 '26 |
Buy |
1.23 |
600 |
738 |
275,366 |
1.17%
2.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):